To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
MPM Capital and Dana-Farber Cancer Institute raise $100m for new fund
MPM Capital and Dana-Farber Cancer Institute have raised $100 million for a new fund that will invest in early-stage biotech companies developing oncology therapeutic technologies.
